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Background-—Telomere length has been inversely associated with cardiovascular disease in adulthood, but its relationship to
preclinical cardiovascular phenotypes across the life course remains unclear. We investigated associations of telomere length with
vascular structure and function in children and midlife adults.
Methods and Results-—Population-based cross-sectional CheckPoint (Child Health CheckPoint) study of 11- to 12-year-old
children and their parents, nested within the LSAC (Longitudinal Study of Australian Children). Telomere length (telomeric genomic
DNA [T]/b-globin single-copy gene [S] [T/S ratio]) was measured by quantitative polymerase chain reaction from blood-derived
genomic DNA. Vascular structure was assessed by carotid intima-media thickness, and vascular function was assessed by carotid-
femoral pulse-wave velocity and carotid elasticity. Mean (SD) T/S ratio was 1.09 (0.55) in children (n=1206; 51% girls) and 0.81
(0.38) in adults (n=1343; 87% women). Linear regression models, adjusted for potential confounders, revealed no evidence of an
association between T/S ratio and carotid intima-media thickness, carotid-femoral pulse-wave velocity, or carotid elasticity in
children. In adults, longer telomeres were associated with greater carotid elasticity (0.14% per 10–mm Hg higher per unit of T/S
ratio; 95% CI, 0.04%–0.2%; P=0.007), but not carotid intima-media thickness (0.9 lm; 95% CI, 14 to 13 lm; P=0.9) or carotid-
femoral pulse-wave velocity (0.10 m/s; 95% CI, 0.3 to 0.07 m/s; P=0.2). In logistic regression analysis, telomere length did not
predict poorer vascular measures at either age.
Conclusions-—In midlife adults, but not children, there was some evidence that telomere length was associated with vascular
elasticity but not thickness. Associations between telomere length and cardiovascular phenotypes may become more evident in
later life, with advancing pathological changes. ( J Am Heart Assoc. 2019;8:e012707. DOI: 10.1161/JAHA.119.012707.)
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G iven the global burden of cardiovascular disease (CVD),considerable efforts are under way to understand the
underlying cause and to identify potential biomarkers
predictive of risk.1 Cell senescence may play an important
role in the progression of CVD, although the upstream drivers
of CVD-associated cell death remain to be fully elucidated.
One well-studied pathway to cellular senescence is mediated
via telomere shortening. Telomeres are nucleoprotein struc-
tures that cap the ends of linear chromosomes. Their
shortening represents a molecular mechanism of biological
aging2 and occurs because of the general inability of cells to
replicate the ends of linear DNA in the absence of
telomerase. At a critical length, the DNA damage response
drives cell senescence, resulting in inhibited tissue repair
capacity and function.
Considerable evidence has linked shorter telomeres with
greater risk of all-causemortality,3 cancer,4 infectious disease,5
and CVD.6,7 Notably, a meta-analysis of 43 725 adults (mean
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age, 60 years) showed that thosewith the shortest telomeres in
blood had a 30% to 83% higher risk of coronary artery disease
relative to those with the longest telomeres.6 Recent studies in
adults have shown accelerated telomere shortening in blood
cells from patients with atherosclerosis.8,9 Few studies have
explored this relationship in relatively healthy populations of
younger individuals, despite the fact that the pathways to
cardiometabolic ill health in adulthood begin much earlier in
life.1 Telomere-linked cell senescence may be on the mecha-
nistic pathway to poor cardiovascular health, or it may
represent a critical “tipping point” in the life course when overt
CVD emerges.
Noninvasive measures of vascular phenotypes enable
assessment of cardiovascular structure and function in the
large arteries. Ultrasound and tonometry of the carotid artery
can capture carotid intima-media thickness (IMT),10,11 carotid-
femoral pulse-wave velocity (PWV), and carotid elasticity.12–14
Carotid IMT is a validated structural marker of subclinical
atherosclerosis and correlates with total atherosclerotic
burden in adults.15 Faster carotid-femoral PWV and reduced
carotid elasticity are functional measures of arterial stiff-
ness14 linked to higher risk of cardiovascular events.16
Thicker carotid IMT has previously been associated with
shorter telomeres in clinical samples of older adults.17,18
However, recent studies of healthy adults in late life showed
that telomere length was not associated with carotid IMT19 or
with carotid atherosclerosis.20 Functional measures have also
been linked with shortened telomeres in later-life adults.21,22
Although telomere length may be a potential mechanism
underlying CVD across the life course, studies are conﬂicting6
and little is known of the relationship in younger adults or
children. It may be that telomere length is associated with
vascular function earlier than structural phenotypes.23 Thus,
exploring the relationship of telomere length with functional
and structural phenotypes across the life course could enhance
our understanding of the role of telomere length-driven cell
senescence in the pathogenesis of CVD. We aimed to assess
the associations of telomere length with measures of vascular
structure and function in a population-based cross-sectional
study of children and their parents.
Materials and Methods
The data that support the ﬁndings of this study are available
from the corresponding author on reasonable request.
Study Design and Participants
The LSAC (Longitudinal Study of Australian Children) recruited
a nationally representative birth cohort in 2004 (n=5107).
Participants have been followed up at 7 biennial waves
spanning birth to 13 years. The CheckPoint (Child Health
CheckPoint) study was an additional physical health and
biomarker wave for the birth cohort, nested between LSAC’s
sixth and seventh waves. During the LSAC wave 6 assessment
in 2014, interviewers obtained written consent from 3513
families (93% of the 3764 seen) to be contacted to participate
in the upcoming CheckPoint study. Ultimately, 1874 adult-
child pairs (50%) took part. Most nonparticipation (60%) was
caused by inability to attend or to reschedule a visit during the
short period CheckPoint study was in each location. Details of
the LSAC and CheckPoint study design and recruitment have
been previously described,24–27 and the Figure shows the ﬂow
through the study.
Data collection ran from February 2015 to March 2016.
The CheckPoint study Assessment Center operated sequen-
tially across Australia in major cities (3.5 hours, main center)
and regional centers (2.5 hours, minicenter), with home visits
offered to those unable to attend a center. Children and their
attending parent rotated through a series of 15-minute
stations, in which different aspects of health were assessed
and biological samples were collected, including venous
blood. A trained researcher undertook cardiovascular mea-
sures while medically trained researchers or phlebotomists
collected venous blood. Samples were processed and cryop-
reserved within 2 hours on site. For the ﬁrst 2 months, this
included blood clots from plasma tubes; for logistic reasons,
clots were then discontinued and replaced with a whole blood
sample for the remaining centers. As each assessment center
closed, samples were transported to the Murdoch Children’s
Research Institute in Melbourne, Australia, where they remain
Clinical Perspective
What Is New?
• This is the ﬁrst study to examine the relationship between
telomere length and vascular structure and function in a
population-based cohort of children and adults.
• In midlife adults, but not children, there was some evidence
that telomere length was associated with vascular elasticity.
• The novel small association between longer telomere length
and higher carotid elasticity in adults is interesting;
however, the strength of the association could equally be
caused by chance and, hence, requires replication.
What Are the Clinical Implications?
• The clinical utility of cross-sectional telomere length
assessment for cardiovascular disease risk in healthy
populations of children or midlife adults is limited.
• Future studies should consider longitudinal associations of
telomere length with vascular phenotypes and cardiovascu-
lar events.
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cryopreserved until depletion. The logistics and speciﬁed
requirements of this large, national, government-owned
population-based cohort precluded any participants attending
repeated sessions. However, all values for all participants in
both age groups are based on repeated measurements within
the same session, as are the interobserver and intraobserver
ratings for the observer-dependent measurements (carotid
IMT and waveform quality ratings). Previous studies have
conﬁrmed similar repeatability between children and
adults,28,29 and between sessions separated by hours to
weeks.30
The study was approved by the Royal Children’s Hospital
Melbourne Human Research Ethics Committee (33225D) and
the Australian Institute of Family Studies Ethics Committee
(14-26). The attending parents provided written informed
consent for themselves and their child before participation,
and the child provided assent.
DNA Isolation and Telomere Length Measurement
Genomic DNA was isolated from available blood using the
QIAamp 96 DNA Blood Kit (Qiagen, Venlo, the Netherlands).
Purity and integrity was conﬁrmed using the NanoDrop 2000
Spectrophotometer (NanoDrop Technologies, Middleton, WI),
the Qubit 2.0 Fluorometer (Thermo Fisher Scientiﬁc, Waltham,
MA), and gel electrophoresis. Telomere length was measured
with the quantitative real-time polymerase chain reaction
method, originally described by Cawthon.31 This method
measures the amount of telomeric genomic DNA (T)/b-globin
single-copy gene (S) (T/S ratio) for each participant. The mean
intra-assay variability between “T” and “S” quadruplicates
used in the calculation of the T/S ratio was 1.7% (SD, 0.3%;
range, 0.9%–2.6%). The interassay variability between plates
was 1.7% (SD, 1.4%; range, 0.3%–6.2%). Further details on the
telomere length calculation (Table S1), plate conditions, and
constituents are described in Data S1 and in the Standard
Operating Procedure on the CheckPoint study’s website.32,33
Carotid IMT and Carotid Elasticity
Carotid IMT and elasticity were measured using standardized
protocols via ultrasound (Vivid i BT06 with 10-MHz linear array
probe; GE Healthcare, Little Chalfont, UK).10,11 Ultrasounds
were performed in supine position with head turned 45° to the
Telomeres measured
Children, n=1,206
Adults, n=1,343
Available blood
Children, n=1,216 
Adults, n=1,350
DNA isolaon failed, n=1
Telomere length assay failed, n=16
LSAC wave 6 Birth cohort (10-12 years)
n=3,764 families
LSAC wave 1 Birth cohort (0-1 years)
n=5,107 families
Child Health CheckPoint (11-12 years)
n=1,874 families
No consent for contact from CheckPoint, n=251
Declined or unable to reschedule, n=1,639
Aended a home visit, n=364
Blood not collected or no consent for use, n=160
Figure. LSAC (Longitudinal Study of Australian Children) and CheckPoint (Child Health CheckPoint) study
participant ﬂow.
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left. The ultrasound probe was applied to the right side of the
neck at 45° to the midline with concurrent 3-lead ECG
trace. The duration of the captured real-time B-mode ultra-
sound cine loops was 10 cardiac cycles.
All images were reviewed for quality to select optimal
loops comprising a clear near and far wall intima-media,
clear lumen, straight vessel, presence of the carotid bulb,
and an ECG trace. The best-quality 5 to 7 cardiac cycle
section of the loops was trimmed and extracted. These
loops were further processed using Carotid Analyzer
(Medical Imaging Applications, Coralville, IA). Raters cali-
brated the images using ultrasound image markers. Max-
imum carotid IMT values were used in analyses, which refer
to the 3 to 5 frame average of the thickest point of carotid
IMT measurement over the highest quality 5- to 10-mm
section from the carotid bulb. After algorithmic detection of
the intima-media interface over the entire cine-loop, frames
were manually adjusted as needed or rejected if the intima-
media interface was unclear or blurred. The intraobserver
variability for the maximum carotid IMT values was 4.9%
(95% CI, 4.6%–5.2%), and the interobserver variability was
6.2% (95% CI, 5.2%–7.2%). Further details are described
elsewhere.25,34
Carotid elasticity was calculated from carotid artery
images and expressed as a percentage change in intima-
intima lumen diameter (measured from ultrasound) per
change in pulse pressure (measured from SphygmoCor), as
previously described (Table S1).13 Intima-intima lumen diam-
eter measurement was automated using Carotid Analyzer and,
thus, was rater independent; it was calculated by measuring
the average intima-intima distance (subtracting near and far
wall IMT measurements) on each of the 3 to 5 still frames
used to calculate maximum carotid IMT. Intraobserver and
interobserver variability values for maximum lumen diameter
were 1.3% (95% CI, 1.2%–1.4%) and 1.6% (95% CI, 1.4%–1.9%),
respectively; and values for minimum lumen diameter were
1.2% (95% CI, 1.1%–1.3%) and 1.5% (95% CI, 1.2%–1.7%),
respectively. Further details are in Data S1 and prior
publications.25,34
Carotid-Femoral PWV and Blood Pressure
Carotid-femoral PWV and blood pressure were measured
using tonometry via SphygmoCor XCEL (AtCor Medical, West
Ryde, Australia), as previously described.14 Carotid-femoral
PWV was determined by detecting waveforms simultaneously
by a hand-held tonometer at the carotid pulse and a cuff
placed on the proximal thigh, over a 10-second period. This
was completed 3 times in the supine position. The distance
traveled by waveforms was measured with a tape measure
from the carotid pulse to the suprasternal notch, from the
suprasternal notch to the right femoral pulse, and from the
femoral pulse to the top of the thigh cuff. The mean of at least
2 valid carotid-femoral PWV measurements (in m/s) was used
in analyses. Systolic and diastolic blood pressure values were
recorded at the brachial artery, 3 times, 1 minute apart, with
either a 23- to 33-cm or a 31- to 40-cm cuff, depending on
arm size. Systolic and diastolic blood pressure values were
included if participants had at least 2 valid measurements.
Further details of these measures are described else-
where.25,35
At the time of assessment, waveforms were assessed using
the in-built quality control software in the SphygmoCor XCEL.
After study completion, waveforms were further reviewed by 2
trained analysts and were excluded if they did not meet quality
control standards. To assess interrater reliability, 112 individ-
ually recorded waves from a random sample of 40 participants
(20 children and 20 adults) from the CheckPoint study database
were presented blindly to 2 analysts for review. Pulse wave
quality ratings given by each analyst (poor, adequate, or good)
were compared by calculating the proportion of positive
agreement between analysts. Most sample waveforms were
of good quality, and none were of poor quality. The overall
correlation between analysts was high (r=0.99). Automated
measurement of carotid-femoral PWV by SphygmoCor is
approved by the US Food and Drug Administration, is exten-
sively standardized across large general populations,22,36,37
and is validated against other well-validated tonometry-based
methods,38,39 as per the ARTERY (Association for Research into
Arterial Structure and Physiology) PWV validation guidelines.40
Published values for interobserver and intraobserver carotid-
femoral PWV variability are 0.30 m/s (SD, 1.25 m/s) and
0.07 m/s (SD, 1.17 m/s), respectively.41 Further details are in
Data S1 and are described elsewhere.25,35
Potential Confounders
Several variables were considered a priori as potential
confounders, including body mass index (BMI; kg/m2),42
socioeconomic status,43 and smoking.44 Each of these
variables has consistently been associated with telomere
length, as well as being commonly known risk factors for
cardiovascular health. BMI was calculated from height
(standard portable stadiometer; IP0955; Invicta, Leicester,
UK) and weight (InBody230 bioelectrical impedance analysis
scale; Biospace Co Ltd Seoul, South Korea). For children, an
age- and sex-adjusted BMI z score was calculated using the
US Centers for Disease Control and Prevention growth
reference charts.45 As a measure of neighborhood socioeco-
nomic status, we used the Socio-Economic Indexes for Areas
Index of Relative Disadvantage score, which is based on the
postcode of domicile of the participating family. This is a
standardized score by geographic area, compiled from 2011
Australian Census data to numerically summarize the social
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and economic conditions of Australian neighborhoods (na-
tional mean of 1000 and SD of 100, where higher values
represent less disadvantage). Parental current smoking
behavior and cigarettes smoked per day were self-reported
at LSAC wave 6. Preexisting conditions were self-reported
(yes/no) by questionnaire at the CheckPoint study assess-
ment, including diabetes mellitus status, heart conditions,
hypertension medication, and pacemakers. Further details of
these sample measures are described elsewhere.25
Other Covariates
Other covariates traditionally associated with cardiovascular
outcomes were measured using the Nightingale nuclear
magnetic resonance metabolomics platform (Helsinki, Fin-
land) from blood serum. These included lipids (total choles-
terol, high-density lipoprotein cholesterol, low-density
lipoprotein cholesterol, and triglycerides), glucose, and the
inﬂammation marker of glycoprotein acetyls. Further details
of this platform and method are extensively described
elsewhere.46
Statistical Analysis
Stata 14.2 (StataCorp, College Station, TX) was used for all
analyses. Continuous variables are presented as means and
SD, whereas dichotomous variables are presented as per-
centages.
Associations of telomere length with vascular measures
were examined by linear and logistic regression models, in
children and adults separately. Assumptions for linear
regression were examined using histograms and scatterplots,
and they showed no discernible outliers and minimal right
skewing for child’s and adult’s telomere length. For aim 1,
linear regression models ﬁtted continuous telomere length as
the independent variable and continuous data on vascular
measures as dependent variables in separate models. For aim
2, logistic regression models ﬁtted continuous telomere
length as the independent variable and elevated carotid IMT,
carotid-femoral PWV, and reduced carotid elasticity as the
dependent variables in separate models. Elevated carotid IMT
and elevated carotid-femoral PWV were deﬁned internally as
>75th percentile for the sample. Reduced carotid elasticity
was deﬁned internally as <25th percentile.
For both aims, model 1 included adjustments for the
potential lifelong confounders of sex and age, as well as for
sample type (ie, whole blood or blood clot) to account for any
effects of the early change in the sample collection protocol
from blood clots to whole blood. Adjusted analyses included
the covariates as independent variables. Model 2 additionally
included adjustments for the additional potential confounders
of BMI and Socio-Economic Indexes for Areas Index of
Relative Disadvantage score, plus smoking status, for adults.
In model 3, we further adjusted for systolic blood pressure,
lipids, glucose, and glycoprotein acetyls. Finally, we con-
ducted sensitivity analysis that did the following: (1) further
adjusted for preexisting conditions, (2) adjusted for mean
arterial pressure or diastolic blood pressure in place of
systolic blood pressure, and (3) stratiﬁed by, rather than
adjusted for, sample type. Sensitivity analyses showed similar
results to those presented below (data not shown; available
on request).
Results
A total of 1874 parent-child dyads participated in the
CheckPoint study (Figure). As venous blood was not collected
at home visits (n=364 dyads), these participants were not
included in the current analysis. Venous blood (whole blood or
blood clot) was available for 1216 children and 1350 adults.
Telomere length data were generated for 1206 children
(99.2%) and 1343 adults (99.5%).
Sample Characteristics
Participant characteristics are displayed in Table 1. Children
and adults were, on average, aged 11 years (SD, 0.5 years)
and 44 years (SD, 5.1 years), respectively. Adults were
predominantly mothers (n=1168; 87%), whereas there were
approximately equal numbers of boys and girls. Participants
came from slightly less disadvantaged and more homoge-
neous areas compared with the national average (mean Socio-
Economic Indexes for Areas Index of Relative Disadvantage
score, 1026 [SD, 61] versus 1000 [SD, 100]). Child and adult
BMI scores were similar to those of the current Australian
population, as recorded by the Australian Bureau of Statistics,
with 1 in 4 children and 2 in 3 adults overweight or obese.47
Compared with the general Australian population rates for
similar age ranges, adults’ self-report of diabetes mellitus
(2.4% versus 4%) and being a current smoker (8% versus 16%)
were lower47 but CVD (2.2% versus 2.5%) was comparable.47
Children had longer telomeres (higher T/S ratio, 1.09; SD,
0.55) than adults (0.81; SD, 0.38).33 Adults, on average, had
thicker carotid IMT than children (663 [SD, 97] lm versus 580
[SD, 46] lm) and stiffer vessels, as shown in faster carotid-
femoral PWV (7.0 [SD, 1.1] m/s versus 4.4 [SD, 0.5] m/s) and
lower carotid elasticity (2.4% [SD, 0.6%] versus 4.8% [SD, 0.9%]
per 10-mm Hg). Further details of the distributions of vascular
phenotypes are in Figure S1 and were previously
described.34,35 Adults with self-reported diabetes mellitus
and hypertension medication use had thicker carotid IMT,
faster carotid-femoral PWV, and lower carotid elasticity
(Table S2). Vascular phenotypes were similar in current
DOI: 10.1161/JAHA.119.012707 Journal of the American Heart Association 5
Telomere Length and Vascular Phenotypes Nguyen et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
smokers and nonsmokers, noting that this may be limited by
lack of smoking history. Telomere length was not related with
diabetes mellitus, current smoking, and hypertension medica-
tion in adults (Table S3). Higher blood pressure was associated
with longer telomeres in adults, but not in children (Table S4).
Association of Telomere Length With Carotid IMT,
Carotid-Femoral PWV, and Carotid Elasticity
In linear regression models adjusted for age, sex, and sample
type, children’s T/S ratio showed little association with
vascular measures (Table 2; model 1). Similarly, adult T/S
ratio showed little association with carotid IMT or carotid-
femoral PWV (Table 2; model 1). However, in adults, longer
telomeres were associated with greater carotid elasticity
(0.14% per 10-mm Hg higher for each additional unit of T/S
ratio; 95% CI, 0.04%–0.2%). This is equivalent to an effect size
of 0.09 SDs higher carotid elasticity for each SD increase in
T/S ratio. This association persisted after adjustments for
sex, age, sample type, BMI, Socio-Economic Indexes for Areas
Index of Relative Disadvantage score, and smoking status
(0.13% per 10-mm Hg; 95% CI, 0.05%–0.20%; Table 2; model
2), as well as for systolic blood pressure, high-density
lipoprotein cholesterol, low-density lipoprotein cholesterol,
triglycerides, glucose, and glycoprotein acetyls (0.09% per
10-mm Hg; 95% CI, 0.003%–0.18%; Table 2; model 3).
In both adults and children, adjusted logistic regression
models showed little evidence of a difference in the odds of
elevated carotid IMT, elevated carotid-femoral PWV, or reduced
carotid elasticity for each unit higher T/S ratio (Table 3).
Discussion
Main Findings
In the present study, we hypothesized that telomere attrition
is an upstream event of cardiometabolic disease and, as such,
evidence for shortened telomeres will be present in mid-aged
adults and children in association with preclinical phenotypes
of poorer cardiovascular health. Furthermore, given the
progressive nature of the proposed association, we predicted
that the strength of association between telomere length and
phenotypes will be stronger in adults relative to their children.
We tested this in a population-based cohort of children and
mid-life adults and found no convincing evidence of associ-
ations between shorter telomeres and adverse vascular
phenotypes at either age, other than a small association
between longer telomere length and increased carotid
elasticity in adults.
Strengths and Limitations
Strengths of our study include the objective examination of
carotid IMT, carotid-femoral PWV, and carotid elasticity with
high reliability and the T/S measurements showing low
replicate variation. We are conﬁdent in interpreting the child
and adult ﬁndings within the same study because they were
assessed at the same time point with the same protocols,
equipment, and staff. For telomere length, we used a
quantitative real-time polymerase chain reaction method that
correlates strongly with the gold standard terminal restriction
fragment analysis.31 However, although well suited for large
epidemiological studies, this method does not quantify
absolute, chromosome-speciﬁc, or vascular tissue-speciﬁc
telomere length. Also, the capacity of telomere length derived
Table 1. Summary Characteristics of Children and Adults
Participant Characteristic Children Adults
Total No. 1206 1343
Age, y 11 (0.5) 44 (5.1)
Female sex, % 51 87
Height, cm 154 (8) 167 (8)
Body mass index, kg/m2 19 (3) 28 (6)
Body mass index z score 0.3 (1) 
Disadvantage score 1026 (62) 1026 (61)
Current smoking, %  8.2
Cigarettes smoked per day  2.6 (0.14)
Preexisting conditions, %
Diabetes mellitus 0.1 2.4
Heart condition  2.2
Hypertension medication  5.1
Pacemakers  0.1
Systolic blood pressure, mm Hg 108 (8) 120 (13)
Diastolic blood pressure, mm Hg 63 (6) 74 (9)
Lumen diameter, mm 5.9 (0.5) 5.8 (0.6)
HDL cholesterol, mg/dL 54 (10) 56 (14)
LDL cholesterol, mg/dL 25 (6) 30 (8)
Total cholesterol, mg/dL 73 (12) 86 (16)
Triglycerides, mg/dL 105 (49) 132 (75)
Glucose, mg/dL 89 (14) 88 (19)
Glycoprotein acetylation, mmol/L 0.99 (0.13) 1.04 (0.17)
Telomere length (T/S ratio) 1.09 (0.55) 0.81 (0.38)
Vascular outcomes
Carotid intima-media thickness, lm 580 (46) 663 (97)
Carotid-femoral pulse wave velocity, m/s 4.4 (0.5) 7.0 (1.1)
Carotid elasticity, % per 10-mm Hg 4.8 (0.9) 2.4 (0.6)
Data are presented as mean (SD) or percentage. HDL indicates high-density lipoprotein;
LDL, low-density lipoprotein; T/S ratio, telomeric genomic DNA (T)/b-globin single-copy
gene (S).
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from blood as a surrogate for telomere length within the
vasculature itself is uncertain; however, there is evidence that
telomere length is highly conserved between tissues.48,49
Differential uptake in LSAC and attrition in CheckPoint study
led to our sample including few fathers and few less
disadvantaged families than in the general Australian popu-
lation. Thus, if such children and adults had both shorter
telomeres and poorer vascular outcomes, this could have
altered estimates and/or their precision. Finally, the cross-
sectional design precluded conclusions about temporal asso-
ciations.
Interpretation in Light of Other Studies
Telomere length, vascular structure, and
atherosclerosis
We found little evidence of an association between telomere
length and carotid IMT. This is consistent with several prior
reports showing no or only marginal associations.17,19,20,50–52
For example, in healthy adults, telomere length was not
independently associated with carotid IMT19 (n=2509; age
range, 35–55 years) and atherosclerosis in the carotid
arteries (n=1459; age range, 40–54 years).20 Together, these
studies suggest that associations between telomere length
and vascular structure appear primarily later in adulthood.
Moreover, there is evidence that shortened telomere length is
more reliably associated with patients with CVD. For example,
shorter telomere length has been observed in aortic tissues
with atherosclerotic lesions, compared with tissues without
atherosclerotic lesions;8 and in another study, telomere
length was associated with advanced-state, but not with
early-stage, atherosclerosis.51 Telomere shortening might
play a role late in the pathogenesis of CVD, in late adulthood
when the effects of cumulative burden over the life course
begin to manifest. This hypothesis would be consistent with
current knowledge, in which the cellular senescence induced
by the aging process is known to trigger the progressive
deterioration of vascular functionality with age.53
Our ﬁndings also align with evidence that shortened
telomere length is associated with vascular phenotypes in
those with greater CVD risk6 (eg, in elderly populations; mean
age, 74.2 years; SD, 5.2 years),17 diabetic subjects,9,54 and
obese men.50 Interestingly, a recent meta-analysis of 5566
patients with coronary artery disease found an overall higher
risk for coronary artery disease in older subjects (≥70 years),
compared with younger subjects (<70 years; relative risk, 1.9
versus 1.5), with respect to individuals in the shortest
telomere tertile compared with those in the longest telomere
tertile.
Telomere length, vascular function, and arterial
stiffness
There was little evidence of an association between telomere
length and carotid-femoral PWV in children or adults. Several
Table 2. Association of Telomere Length With Carotid IMT, Carotid-Femoral PWV, and Carotid Elasticity, in Children and Adults
Outcome
Children Adults
No. Coefﬁcient (95% CI) R2 P Value No. Coefﬁcient (95% CI) R2 P Value
Model 1*
Carotid IMT, lm 1193 4.11 (1.21 to 9.4) 0.04 0.13 1203 0.85 (14.31 to 12.61) 0.16 0.90
Carotid-femoral PWV, m/s 1167 0.01 (0.07 to 0.06) 0.06 0.86 1110 0.10 (0.27 to 0.07) 0.10 0.23
Carotid elasticity, % per 10-mm Hg 1083 0.04 (0.15 to 0.06) 0.01 0.42 1040 0.14 (0.04 to 0.24) 0.12 0.007
Model 2†
Carotid IMT, lm 1192 4.67 (0.64 to 9.99) 0.05 0.09 1198 0.46 (12.71 to 13.64) 0.20 0.95
Carotid-femoral PWV, m/s 1166 0.01 (0.05 to 0.07) 0.13 0.68 1106 0.12 (0.28 to 0.04) 0.24 0.13
Carotid elasticity, % per 10-mm Hg 1082 0.06 (0.17 to 0.05) 0.04 0.26 1035 0.13 (0.04 to 0.22) 0.26 0.006
Model 3‡
Carotid IMT, lm 1082 4.89 (0.60 to 10.37) 0.07 0.08 1082 1.17 (12.60 to 14.94) 0.25 0.87
Carotid-femoral PWV, m/s 1070 0.02 (0.04 to 0.08) 0.16 0.57 1031 0.09 (0.23 to 0.06) 0.40 0.24
Carotid elasticity, % per 10-mm Hg 1037 0.09 (0.19 to 0.02) 0.15 0.11 1003 0.09 (0.003 to 0.18) 0.36 0.04
IMT indicates intima-media thickness; PWV, pulse-wave velocity; R2, value for the linear regression model.
*Model 1 was adjusted for sex, age, and sample type.
†Model 2 was additionally adjusted for body mass index, Socio-Economic Indexes for Areas Index of Relative Socioeconomic Disadvantage score, plus smoking status for adults.
‡Model 3 was additionally adjusted for brachial systolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, glucose, and glycoprotein
acetylation.
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recent studies have reported an association between shorter
telomeres and faster carotid-femoral PWV, but most have
been in older adults (>50 years), were limited by modest
sample sizes (range, 49–303 individuals),21,37,54 and were
predominately in men.21,55 For example, Benetos et al
showed that shorter telomere length was signiﬁcantly asso-
ciated with faster carotid-femoral PWV in men (n=120; mean
age, 55 years; r=0.14), but not in women (n=73; mean age,
56 years; r=0.05).55 Similar results were also found in a
study of healthy Chinese men (n=112; mean age, 56 years).21
We cannot tell whether our lack of association between
telomere length and carotid-femoral PWV reﬂects our pre-
ponderance of women or the younger age in our sample.
Interestingly, previous ﬁndings suggest that age signiﬁcantly
modiﬁes the relationship between telomere length and
carotid-femoral PWV in healthy individuals,22 an effect not
observed in our study.
In summary, we report a novel, albeit small, association
between telomere length and carotid elasticity in adults,
which remained after adjustment for a priori speciﬁed
confounders. Although speculative at this point, this suggests
a possibility that cellular senescence might contribute to
vascular function, through the elasticity of the vasculature.
One hypothesis might be that the secretory phenotype of
senescent vascular cells might promote vascular degenera-
tion through the destabilization of extracellular matrix, elastin,
collagen, and smooth muscle,12 thus modifying the elasticity
of the carotid artery. However, we suspect that it would also
have effects on overall arterial stiffness and, thus, affect
carotid-femoral PWV, which we did not ﬁnd. This discordance
warrants further investigation. We note that although vascular
structure and function are considered to be related, they
ultimately measure different properties of the arterial tree,
both likely affected by risk factors in a nonuniform manner. It
has been documented that functional changes precede the
development of structural alterations in the vasculature.23
Clinical Implications, Unanswered Questions, and
Future Direction
Our ﬁndings, if replicated in other settings, question the
clinical utility of measuring telomere length in healthy
relatively young populations. The magnitude of the cross-
sectional association between telomere length and carotid
elasticity observed among adults was small. In addition, the
European Society of Hypertension and the European Society
of Cardiology noted that a carotid IMT of >900 lm and a
carotid-femoral PWV of >12 m/s are associated with
increased CVD risk,56 thresholds not reached by our relatively
healthy cohort of children and adults. This suggests that the
magnitude of the associated changes is unlikely to represent
clinically signiﬁcant differences on CVD risk, especially in
largely healthy populations of children or mid-life adults.
However, telomere length might be of greater clinical
Table 3. Odds Ratio for Elevated Carotid IMT, Elevated Carotid-Femoral PWV, and Reduced Carotid Elasticity for 1 Unit Higher T/S
Ratio, in Children and Adults
Outcome
Children Adults
No. Odds Ratio (95% CI) P Value No. Odds Ratio (95% CI) P Value
Model 1*
Elevated carotid IMT 1193 1.23 (0.94–1.61) 0.13 1203 0.94 (0.65–1.37) 0.77
Elevated carotid-femoral PWV 1167 0.82 (0.60–1.13) 0.23 1110 0.88 (0.59–1.30) 0.56
Reduced carotid elasticity 1083 0.99 (0.73–1.32) 0.92 1040 0.84 (0.55–1.30) 0.44
Model 2†
Elevated carotid IMT 1192 1.27 (0.97–1.66) 0.08 1198 0.98 (0.67–1.44) 0.92
Elevated carotid-femoral PWV 1166 0.88 (0.63–1.23) 0.47 1106 0.83 (0.54–1.28) 0.40
Reduced carotid elasticity 1082 1.02 (0.76–1.38) 0.91 1035 0.83 (0.52–1.32) 0.42
Model 3‡
Elevated carotid IMT 1082 1.26 (0.95–1.68) 0.11 1082 1.03 (0.66–1.61) 0.89
Elevated carotid-femoral PWV 1070 0.97 (0.68–1.38) 0.86 1031 0.73 (0.43–1.24) 0.25
Reduced carotid elasticity 1037 1.16 (0.84–1.58) 0.37 1033 1.03 (0.61–1.74) 0.92
Elevated carotid IMT deﬁned as >75th percentile, elevated carotid-femoral PWV deﬁned as >75th percentile, and reduced carotid elasticity deﬁned as <25th percentile. IMT indicates
intima-media thickness; PWV, pulse-wave velocity; T/S ratio, telomeric genomic DNA (T)/b-globin single-copy gene (S).
*Model 1 was adjusted for sex, age, and sample type.
†Model 2 was additionally adjusted for body mass index, Socio-Economic Indexes for Areas Index of Relative Socioeconomic Disadvantage score, plus smoking status for adults.
‡Model 3 was additionally adjusted for brachial systolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, glucose, and glycoprotein
acetylation.
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relevance at an advanced age or in association with more
pronounced vascular pathological features. Moreover, it is
possible that such associations could be important longitu-
dinally, such that the rate of telomere attrition, rather than
cross-sectional telomere length per se, may be a more
clinically important cardiovascular risk marker. Indeed, in a
recent British longitudinal study (baseline n=2611; mean age,
53 years; follow-up age range, 60–64 years), an association
was observed between the rate of telomere attrition and
thicker carotid IMT at 60 to 64 years, despite limited cross-
sectional associations.18 Future studies should consider
longitudinal evaluation with repeated telomere sampling to
assess whether telomere attrition over time is associated with
vascular phenotypes and cardiovascular events.
We cannot exclude the possibility that our ﬁndings may
have arisen by chance, and might be explained by factors
beyond the scope of this study, including genetic variation
and other unmeasured environmental exposures. The ability
of carotid ultrasounds and tonometry to effectively measure
meaningful changes in vascular structure and function in
healthy individuals is also uncertain. In particular, the
predictive value of carotid IMT measurement in children aged
11 to 12 years without CVD risk remains unclear.57
Conclusion
In a healthy cohort of children and mid-life adults, we report
limited evidence that cellular senescence, as measured by
telomere length, is associated with vascular structure or
function in children or adults. The novel small association
between longer telomere length and higher carotid elasticity in
adults is interesting, supporting our hypothesis that telomere
length may be on the mechanistic pathway toward impaired
vascular function; however, the strength of the association
could equally be caused by chance and, hence, requires
replication. Although telomere length may be important for
individuals at intermediate to high CVD risk or those at
advanced disease stages, as previously reported, cross-
sectional telomere length assessment appears to have limited
clinical value for CVD risk in healthy populations, particularly at
younger ages. The interaction between telomere dynamics and
vascular phenotypes across the life course is multifaceted, with
contributions from genetic variation and environmental expo-
sures. Further longitudinal investigations, with repeated telom-
ere and vascular phenotypic sampling, are warranted.
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Data S1. 
Supplemental Methods 
Blood collection and genomic DNA isolation 
Whole venous blood was collected into vacutainer tubes containing 
ethylenediaminetetraacetic acid (known as EDTA) and immediately transported to an on-site 
laboratory. The blood sample was processed into aliquots within 2 hours into 1.0 mL FluidX 
tubes (FluidX, Cheshire, UK) and frozen in a -80 ˚C ultra-low temperature freezer (Thermo 
Fisher Scientific, Waltham, USA). Samples were transported to the Murdoch Children’s 
Research Institute (MCRI) biobank. Genomic DNA was isolated from available blood (e.g. 
whole blood or blood clot) using the Qiaamp 96 DNA Blood Kit (Qiagen, Venlo, Netherlands). 
Samples were randomised with child and parent dyads on the same plate to minimise batch 
effects using a random number generator (Stata 14.2, StataCorp LLC, USA). The sample 
retrieval, protocol optimisation, consumable acquisition, and isolation of genomic DNA 
spanned April 2016 to January 2017. Purity and integrity of genomic DNA was confirmed 
using NanoDrop 2000 spectrophotometer (NanoDrop Technologies, Middleton, USA), Qubit 
2.0 Fluorometer (Thermo Fisher Scientific, Waltham, USA) and gel electrophoresis, prior to 
storage in a -80 ˚C ultra-low temperature freezer (Thermo Fisher Scientific, Waltham, USA). 
Genomic DNA was also isolated from 3 sets of control samples: (1) the K562 leukemic cell 
line, (2) newborn cord blood and (3) human placental tissue. These control samples have 
previously been described as having ‘shorter’, ‘average’ and
‘longer’ telomeres relative to peripheral blood samples.1-4 Genomic DNA from each of these 
control samples was used on all telomere assays to assess day-to-day and plate effects.
Telomere length measurement 
Each sample was measured in quadruplicates comprising 4 μl of diluted genomic DNA at 5 
ng/μl, 5 μl of SensiFAST SYBR No-ROX Kit master mix (Bioline, Sydney, Australia) and 0.5 
μl of each forward and reverse primer at 2 μM. The primer sequences were tel1 (5’-CGG 
TTT GTT TGG GTT TGG GTT TGG GTT TGG GTT TGG GTT), tel2 (5’-GGC TTG CCT 
TAC CCT TAC CCT TAC CCT TAC CCT TAC CCT), bg1 (5’-GCA GGA GCC AGG GCT 
GGG CAT AAA AGT CA) and bg2 (5’-GGG CCT CAC CAC CAA CTT CAT CCA CGT TC). 
All ‘T’ and ‘S’ reactions were performed in 384-well plates on a Lightcycler 480 Instrument II 
(Roche, Melbourne, Australia). The cycling condition began with incubation at 95°C for 10 
minutes, followed by 35 cycles of (i) 95°C for 15 seconds and (ii) 62°C for 60 seconds. The 
final 384-well layout included participant genomic DNA, three sets of control genomic DNA 
and a no-template control containing RNase-free water instead of a genomic DNA template, 
each present in quadruplicates. Further details are described in the standard operating 
procedure on the Growing Up in Australia's CheckPoint website.5 
Calculation of telomere length 
A ratio, known as the T/S ratio, is calculated by comparing the relative amount of ‘T’ and ‘S’ 
for each of these samples to a reference genomic DNA sample (in this case the average T/S 
ratio of all control genomic DNA). The final relative telomere length from each sample, based 
on the T/S ratio, was calculated as the change in cycle threshold (Ct) of the test sample 
(Table S1), normalised to the average T/S ratio of the control genomic DNA on the 
corresponding plate (Table S2). Hence, the final equation is shown in Table S3. If less than 
two successful replicates out of the quadruplicates for either ‘T’ and ‘S’ were measured then 
the sample data was omitted (n=16), otherwise a median was calculated, resulting in a 
median ‘T’ and a median ‘S’ for each sample 
(n=2,549). A Ct replicate from 5 to 28 was considered successful as a Ct outside of this 
range was uncertain. 
Telomere length replicate variability 
To assess the replicate reliability, the degree of variation between replicates in the assay 
plate, an intra-assay coefficient of variation was calculated. The intra-assay coefficient of 
variation was calculated as the ratio of the pooled Ct’s standard deviation (SD) from all 
samples (each was analysed in quadruplicate) and the overall Ct mean, and then multiplied 
by 100. To assess the degree of assay-to-assay and day-to-day consistency an inter-assay 
coefficient of variation was calculated using the pooled Ct’s SD divided by the overall Ct 
mean of all duplicated samples, and then multiplied by 100. The mean intra-assay variability 
between ‘T’ and ‘S’ quadruplicates used in the calculation of the T/S ratio was 1.7 % (SD 
0.3; range 0.9-2.6). The inter-assay variability between plates was 1.7 % (SD 1.4; range 0.3-
6.2). 
Reliability of carotid intima-media thickness (IMT) readings 
Six trained raters analysed all cine-loops. Training consisted of thirty example cine-loops 
that were subsequently assessed for consistency by an expert rater. Inter- and intra-
observer variability was assessed by reanalysing a subset of 105 randomly-selected child 
images four times at the end of the scoring process. Images were reassessed twice each by 
two raters in a balanced incomplete block design as not all raters assessed the complete 
subset. This allowed estimation of the repeatability of measurements made by the same 
rater and the reproducibility of measurements made by different raters. Image acquisition 
was only performed once.  
In our reliability analysis, we used the modelling of repeated measurements on carotid IMT 
films with rater and participant as random effects to estimate between-participant variance, 
between-rater variance, and residual error variance. These were used to calculate intra- and 
inter-observer variability (the degree of measurement error proportional to the mean.) For 
maximum carotid IMT value, the intra-observer variability was 4.9% (95% CI 4.6-5.2) and the 
inter-observer variability was 6.2% (95% CI 5.2-7.2). 
Reliability of carotid elasticity 
Carotid elasticity measures the ability of the arteries to expand as a response to pulse 
pressure caused by cardiac contraction and relaxation.6 Carotid elasticity was calculated 
from carotid artery images and expressed as a percentage change in intima-intima lumen 
diameter per change in pulse pressure (Table I), according to previously published work 
from the Cardiovascular Risk in Young Finns Study6 and other related studies.7 Intima-intima 
lumen diameter measurement was automated using Carotid Analyser (Medical Imaging 
Applications, Coralville, IA, USA), rater-independent, and was calculated by measuring the 
average intima-intima distance (subtracting near and far wall IMT measurements) on each of 
the three to five still frames used to calculate maximum carotid IMT. The final calculation is 
shown in Table S1 (IV). 
After algorithmic detection of the intima-media interface over the entire cine-loop by Carotid 
Analyser (Medical Imaging Applications, Coralville, IA, USA), frames were manually adjusted 
as needed or rejected if the intima-media interface was unclear or blurred. Intra- and inter-
observer variability for maximum lumen diameter was 1.3% (95% CI 1.2-1.4) and 1.6% (95% 
CI 1.4-1.9). Intra- and inter-observer variability for minimum lumen diameter was 1.2% (95% 
CI 1.1-1.3) and 1.5% (95% CI 1.2-1.7). 
Reliability of arterial pulse waveforms 
Twenty children and twenty parents were randomly sampled from the SphygmoCor 
database and sampling was stratified by two analysts. Hence, twenty subjects were chosen 
from each analyst. The pulse wave analysis (PWA) waveforms had already undergone 
quality checks by one of these two trained data analysts. Each child provided three 
individually recorded PWA and whilst temporally close they were not necessarily 
exchangeable and were treated as linked for rating purposes. Waves were presented to the 
analyst without evidence of previous quality assessment. Three waves were present for 32 
children and two waves for 8 children, resulting in each analyst making 112 assessments. 
Waves from the same subject were identifiable as they were presented sequentially for 
assessment. To assess the quality of the PWA waveforms we compared the quality ratings 
(1 good, 2 adequate and 3 poor) assigned by each analyst. 
We compared quality ratings of the PWA waveforms by calculating the proportion of positive 
and negative agreement between analysts. No waves were classified as being of poor 
quality. The positive agreement between analysts was high (0.99). There were 
discrepancies in quality ratings for only two waveforms and therefore the negative 
agreement (0.5) was likely a poor estimate. Overall both analysts agreed that all scans were 
of acceptable quality or above.
Table S1. Equations for the calculation of (I, II and III) telomere length and (IV) carotid elasticity. 
Equation 
(I) Change in cycle threshold for test sample ∆𝐶𝑡𝑡𝑒𝑠𝑡 = 𝐶𝑡(𝑡𝑒𝑠𝑡,   𝑡𝑒𝑙𝑜𝑚𝑒𝑟𝑒) −  𝐶𝑡(𝑡𝑒𝑠𝑡,   𝑏𝑒𝑡𝑎−𝑔𝑙𝑜𝑏𝑖𝑛) 
(II) Change in cycle threshold for reference sample ∆𝐶𝑡𝑟𝑒𝑓 = 𝐶𝑡(𝑟𝑒𝑓,   𝑡𝑒𝑙𝑜𝑚𝑒𝑟𝑒) −  𝐶𝑡(𝑟𝑒𝑓,   𝑏𝑒𝑡𝑎−𝑔𝑙𝑜𝑏𝑖𝑛) 
(III) Relative telomere length (T/S ratio) 2−∆∆𝐶𝑡 = 2−(∆𝐶𝑡𝑡𝑒𝑠𝑡− ∆𝐶𝑡𝑟𝑒𝑓)
(IV) Carotid elasticity (%/mmHg) (
𝐿𝐷𝑚𝑎𝑥 − 𝐿𝐷𝑚𝑖𝑛
𝐿𝐷𝑚𝑖𝑛
)
∆𝑃𝑃
× 100% 
Table S2. Summary of adults’ vascular outcomes for diabetics, current smokers and hypertension medications users. 
Carotid IMT (µm) Carotid-femoral PWV (m/s) Carotid elasticity (% per 10 mmHg) 
N Mean (SD) p-value* N Mean (SD) p-value* N Mean (SD) p-value*
Diabetes 
Yes 30 758 (170) - 24 7.81 (1.39) - 22 2.05 (0.63) - 
 No 1286 661 (93) 0.004 1176 6.94 (1.11) 0.006 1105 2.44 (0.60) 0.008 
Current smoker 
Yes 110 658 (91) - 94 6.78 (1.08) - 94 2.43 (0.62) - 
No 1206 664 (97) 0.51 1106 6.97 (1.12) 0.11 1033 2.44 (0.60) 0.95 
Hypertension medication 
Yes 66 720 (124) - 55 8.00 (1.40) - 52 2.13 (0.50) - 
No 1250 660 (94) 0.0002 1145 6.91 (1.08) <0.0001 1075 2.45 (0.60) <0.0001 
SD: standard devation. 
* Student’s t-test.
current smokers and Table S3. Summary of adult T/S ratios for diabetics, hypertension 
medication users. 
Telomere length (T/S ratio) 
N Mean (SD) p-value*
Diabetes 
Yes 32 0.76 (0.30) - 
 No 1312 0.81 (0.38) 0.40 
Current smoker 
Yes 110 0.77 (0.34) - 
No 1234 0.81 (0.38) 0.20 
Hypertension medication 
Yes 68 0.78 (0.36) - 
No 1276 0.81 (0.38) 0.48 
SD: standard devation. 
* Student’s t-test.
outcome), in children and adults Table S4. Association of brachial systolic blood pressure (exposure) with telomere length ( separately. 
per 10 mmHg Children Adults 
Outcome N Coefficient (95% CI) p-value N Coefficient (95% CI) p-value
Model 1* 
T/S ratio 1140 -0.02 (-0.06 to 0.02) 0.25 1141 -0.02 (-0.04 to -0.002) 0.03 
Model 2† 
T/S ratio 1139 -0.002 (-0.04 to 0.04) 0.92 1136 -0.02 (-0.04 to -0.002) 0.03 
* Model 1 adjusted for sex, age and sample type.
† Model 2 additionally adjusted for body mass index, Socio-Economic Indexes for Areas Index of Relative Socioeconomic Disadvantage score, 
plus smoking status for adults. 
Figure S1. Children’s (green, solid) and adults’ (blue, dash) distribution of (I) carotid intima-media thickness, (II) carotid-femoral pulse wave 
velocity, (III) carotid elasticity and (IV) telomere length. 
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